IBB vs. SPY
IBB (iShares Nasdaq Biotechnology ETF) and SPY (State Street SPDR S&P 500 ETF) are both exchange-traded funds - IBB is a Health & Biotech Equities fund tracking the NASDAQ Biotechnology Index, while SPY is a S&P 500 fund tracking the S&P 500 Index. Both are passively managed. Over the past 10 years, IBB returned 8.14%/yr vs 15.70%/yr for SPY. A 0.67 correlation means they provide meaningful diversification when combined. IBB charges 0.47%/yr vs 0.09%/yr for SPY.
Performance
IBB vs. SPY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IBB achieves a 4.97% return, which is significantly lower than SPY's 9.74% return. Over the past 10 years, IBB has underperformed SPY with an annualized return of 8.14%, while SPY has yielded a comparatively higher 15.70% annualized return.
IBB
- 1D
- 1.94%
- 1M
- 4.88%
- YTD
- 4.97%
- 6M
- 2.54%
- 1Y
- 41.38%
- 3Y*
- 11.58%
- 5Y*
- 2.25%
- 10Y*
- 8.14%
SPY
- 1D
- -0.31%
- 1M
- 0.09%
- YTD
- 9.74%
- 6M
- 9.27%
- 1Y
- 26.65%
- 3Y*
- 21.27%
- 5Y*
- 13.51%
- 10Y*
- 15.70%
IBB vs. SPY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
IBB iShares Nasdaq Biotechnology ETF | 4.97% | 27.98% | -2.41% | 3.76% | -13.69% | 0.95% | 26.01% | 25.42% | -9.53% | 21.08% |
SPY State Street SPDR S&P 500 ETF | 9.74% | 17.72% | 24.89% | 26.18% | -18.18% | 28.73% | 18.33% | 31.22% | -4.57% | 21.71% |
Correlation
The correlation between IBB and SPY is 0.50, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.50 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.56 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.62 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.62 |
Correlation (All Time) Calculated using the full available price history since Feb 12, 2001 | 0.67 |
The correlation between IBB and SPY shifts across timeframes, from 0.50 (1 year) to 0.67 (all time), reflecting how their relationship changes across market environments.
IBB vs. SPY - Sectors Allocation Comparison
Sectors
IBB
SPY
Healthcare
Basic Materials
-
Communication Services
-
Consumer Cyclical
-
Consumer Defensive
-
Energy
-
Financial Services
-
Industrials
-
Real Estate
-
Technology
-
Utilities
-
Healthcare
IBB
SPY
Basic Materials
IBB
-
SPY
Communication Services
IBB
-
SPY
Consumer Cyclical
IBB
-
SPY
Consumer Defensive
IBB
-
SPY
Energy
IBB
-
SPY
Financial Services
IBB
-
SPY
Industrials
IBB
-
SPY
Real Estate
IBB
-
SPY
Technology
IBB
-
SPY
Utilities
IBB
-
SPY
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IBB vs. SPY — Risk / Return Rank
IBB
SPY
IBB vs. SPY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq Biotechnology ETF (IBB) and State Street SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IBB | SPY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.11 | ||
| Sortino ratioReturn per unit of downside risk | -0.03 | ||
| Omega ratioGain probability vs. loss probability | 1.34 | 1.39 | -0.05 |
| Calmar ratioReturn relative to maximum drawdown | 4.32 | 3.01 | +1.30 |
| Martin ratioReturn relative to average drawdown | 13.28 | 13.54 | -0.25 |
Loading charts...
Drawdowns
IBB vs. SPY - Drawdown Comparison
The maximum IBB drawdown since its inception was -62.85%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for IBB and SPY.
Loading charts...
Drawdown Indicators
| IBB | SPY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -62.85% | -55.19% | -7.66% |
Max Drawdown (1Y)Largest decline over 1 year | -9.63% | -8.88% | -0.75% |
Max Drawdown (3Y)Largest decline over 3 years | -24.85% | -18.76% | -6.09% |
Max Drawdown (5Y)Largest decline over 5 years | -39.82% | -24.50% | -15.32% |
Max Drawdown (10Y)Largest decline over 10 years | -39.82% | -33.72% | -6.10% |
Current DrawdownCurrent decline from peak | -0.27% | -1.75% | +1.48% |
Average DrawdownAverage peak-to-trough decline | -21.15% | -9.04% | -12.11% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.12% | 1.97% | +1.15% |
Volatility
IBB vs. SPY - Volatility Comparison
iShares Nasdaq Biotechnology ETF (IBB) has a higher volatility of 6.96% compared to State Street SPDR S&P 500 ETF (SPY) at 4.64%. This indicates that IBB's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IBB | SPY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.96% | 4.64% | +2.32% |
Volatility (6M)Calculated over the trailing 6-month period | 15.99% | 9.75% | +6.24% |
Volatility (1Y)Calculated over the trailing 1-year period | 20.37% | 12.43% | +7.94% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.03% | 17.14% | +4.89% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.22% | 17.99% | +5.23% |
IBB vs. SPY - Expense Ratio Comparison
IBB has a 0.47% expense ratio, which is higher than SPY's 0.09% expense ratio.
Dividends
IBB vs. SPY - Dividend Comparison
IBB's dividend yield for the trailing twelve months is around 0.23%, less than SPY's 1.01% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IBB iShares Nasdaq Biotechnology ETF | 0.23% | 0.23% | 0.29% | 0.26% | 0.31% | 0.21% | 0.21% | 0.33% | 0.20% | 0.30% | 0.19% | 0.03% |
SPY State Street SPDR S&P 500 ETF | 1.01% | 1.07% | 1.21% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% |
Frequently Asked Questions
IBB and SPY have a correlation of 0.50, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IBB has higher volatility (6.96%) compared to SPY (4.64%). In terms of maximum drawdown, IBB dropped -62.85% vs SPY's -55.19%.
On 10-year performance, SPY leads with 15.70% vs 8.14% for IBB. On fees, SPY is cheaper at 0.09% per year. On volatility, SPY has been the lower-risk option at 4.64%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, SPY has performed better with a 15.70% return vs 8.14%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
SPY is cheaper with a 0.09% expense ratio, compared with 0.47% for IBB.
SPY has the higher dividend yield at 1.01%, compared with 0.23% for IBB.
IBB is categorized as Health & Biotech Equities, while SPY is S&P 500. IBB tracks NASDAQ Biotechnology Index, while SPY tracks S&P 500 Index. They also come from different issuers: iShares and State Street. Their fees differ too: 0.47% for IBB and 0.09% for SPY.
SPY currently has the higher Sharpe Ratio (2.16 vs 2.05), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IBB and SPY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer